Curi Bio logo

Curi Bio

curibio.com

Curi Bio provides integrated platforms that combine advanced 3D human tissue models, biosystems for functional analysis, and AI-enabled data analytics to support drug discovery and preclinical R&D. Its products and services are used by pharmaceutical and biotechnology companies to improve the predictive accuracy of drug safety, efficacy, and potency assessments, with a focus on cardiac, skeletal muscle, and disease models. The organization aims to accelerate the development of next-generation human medicines by integrating human cells, systems, and data.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2015
Type
Corporation Seattle business license
Employees
51
Registered name
Nanosurface Biomedical Inc Seattle business license
Stage
Series B
Founders
Elliot Fisher

Is this your organization? Claim it

Curi Bio Expands Curiverse with Disease-Specific iPSC Models, Casting Kits, and Assays for Cardiac, Skeletal Muscle, and Neuromuscular Research

Curi Bio expanded its Curiverse ecosystem to offer disease-specific iPSC models, casting kits, validated assays, and integrated research services for cardiac, skeletal muscle, and neuromuscular applications, enabling researchers to accelerate human-relevant drug discovery without building models in-house.

See all 11 stories, episodes and videos about Curi Bio.

People

  • Elliot Fisher Co-Founder & Chief Business Officer
  • Michael Cho Executive, Chief Strategy Officer
  • Nicholas Geisse Executive, Chief Executive Officer

Online